Ischemic stroke and use of estrogen and estrogen/progestogen as hormone replacement therapy.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Stroke

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.STR.29.1.23PMID 9445323
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Postmenopausal estrogen and progestin use and the risk of cardiovascular disease.

  1996cited by this paper
• Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden.

  1993cited by this paper
• Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort.

  1993cited by this paper
• A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women.

  1993cited by this paper
• Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women

  1992cited by this paper
• Decreased Mortality in Users of Estrogen Replacement Therapy

  1991cited by this paper
• Thromboxane A2 in severe hypertension and stroke in stroke-prone spontaneously hypertensive rats.

  1988cited by this paper
• Stroke incidence and risk factors for stroke in Copenhagen, Denmark.

  1988cited by this paper
• Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.

  1987cited by this paper
• Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study.

  1985cited by this paper
• The role of estrogens as a risk factor for stroke in postmenopausal women.

  1980cited by this paper
• Risk of vascular disease in women. Smoking, oral contraceptives, noncontraceptive estrogens, and other factors.

  1979cited by this paper
• Effects of long-term estrogen replacement therapy. I. Metabolic effects.

  1979cited by this paper
• Estrogen use and stroke risk in postmenopausal women.

  1976cited by this paper

• Hormone Replacement Therapy and Mortality for Ischaemic Heart Disease, Cerebrovascular Diseases and Breast Cancer in Italy and the U.S.A

  2020cites this paper
• Hormone Replacement Therapy and Mortality for Ischaemic Heart Disease , Cerebrovascular Diseases and Breast Cancer in Italy and the U .

  2019cites this paper
• Hormone Replacement Therapy and Mortality for Ischaemic Heart Disease, Cerebrovascular Diseases and Breast Cancer in Italy and the U.S.A

  2019cites this paper
• Sex hormones and stroke: Beyond estrogens.

  2019cites this paper
• Hormone Replacement Therapy and Mortality for Ischaemic Heart Disease , Cerebrovascular Diseases and Breast Cancer in Italy and the U .

  2018cites this paper
• Postmenopausal Hormone Therapy and Risk of Stroke

  2016cites this paper
• The Impact of Aging on Ischemic Stroke

  2016cites this paper
• Hormone Use and Stroke

  2016cites this paper
• Estrogen Therapy and Ischemic Stroke in Women with Diabetes Aged Over 55 Years: A Nation-Wide Prospective Population-Based Study in Taiwan

  2015cites this paper
• THE SERUM LEVEL OF ESTROGEN AND PROGESTERONE AND THEIR RATIO IN PATIENTS WITH ISCHEMIC STROKE: A COMPARATIVE STUDY

  2015cites this paper
• Cerebrovascular Stroke: Sex Differences and the Impact of Estrogens

  2015cites this paper
• Progesterone as a neuroprotectant in stroke

  2013cites this paper
• Revisiting the timing hypothesis: biomarkers that define the therapeutic window of estrogen for stroke.

  2013cites this paper
• Alphaxalone inhibits growth, migration and invasion of rat C6 malignant glioma cells.

  2013cites this paper
• Hormone Therapy Administration in Postmenopausal Women and Risk of Stroke

  2011cites this paper
• Risk factors for Ischemic Stroke in Patients attending Tertiary Hospital in Quetta

  2010cites this paper
• Hormone therapy and stroke: Is it all about timing?

  2009cites this paper
• Estrogen and Stroke: A Review of the Current Literature

  2009cites this paper
• Statistical adjustment for a measure of healthy lifestyle doesn’t yield the truth about hormone therapy

  2008cites this paper
• Peculiarities of Stroke Risk in Women

  2007cites this paper
• Postmenopausal hormone therapy in clinical perspective

  2007cites this paper
• Medical decisions, estrogen and aging

  2007cites this paper
• Randomized Controlled Trials and the Effects of Postmenopausal Hormone Therapy on Cardiovascular Disease: Facts, Hypotheses, and Clinical Perspective

  2007cites this paper
• Risk of ischemic stroke and lifetime estrogen exposure

  2007cites this paper
• Estrogens as Neuroprotectants against Ischemic Stroke

  2006cites this paper
• Advancing the Study of Stroke in Women: Summary and Recommendations for Future Research From an NINDS-Sponsored Multidisciplinary Working Group

  2006cites this paper
• Hormone Replacement Therapy and Stroke: The Current State of Knowledge and Directions for Future Research

  2006cites this paper
• Hormone therapy and cerebrovascular events: a population-based nested case-control study

  2006cites this paper
• Differential modulation of estrogen receptors (ERs) in ischemic brain injury: a role for ERalpha in estradiol-mediated protection against delayed cell death.

  2006cites this paper
• Estrogens and Experimental Ischemic Stroke: A Systematic Review

  2006cites this paper
• Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.

  2005cites this paper
• Oestrogen and stroke in women: assessment of risk.

  2005cites this paper
• Modulatory effects of progesterone on inducible nitric oxide synthase expression in vivo and in vitro

  2005cites this paper
• A comparative review of the risks and benefits of hormone replacement therapy regimens.

  2004cites this paper
• Approaches to prevention of a first stroke

  2004cites this paper
• Progesterone Enhances Functional Recovery after Middle Cerebral Artery Occlusion in Male Mice

  2004cites this paper
• Different cerebrovascular effects of medroxyprogesterone acetate and norethisterone acetate in the New Zealand White rabbit

  2004cites this paper
• 17 β‐Estradiol prevents focal cerebral ischemic damages via activation of Akt and CREB in association with reduced PTEN phosphorylation in rats

  2004cites this paper
• Stroke

  2004cites this paper
• [Women and strokes: specific therapy for female patients].

  2003cites this paper
• Traitement hormonal substitutif et risque cardiovasculaire : non indication ou contre-indication ?

  2003cites this paper
• [Hormonal replacement therapy and cardiovascular risk: contra-indication or non-indication?].

  2003cites this paper
• HORMONE THERAPY IN SELECTED POSTMENOPAUSAL WOMEN AT RISK FOR OSTEOPOROSIS

  2003cites this paper
• Estrogens: protective or risk factors in brain function?

  2003cites this paper
• Effect of hormone replacement therapy on cardiovascular disease: current opinion

  2003cites this paper
• HRT: decide based on the evidence.

  2003cites this paper
• Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial.

  2003cites this paper
• Postmenopausal hormone replacement therapy: scientific review.

  2002cites this paper
• Ischemic stroke in a man using estrogen.

  2002cites this paper
• Loss of benefit from estrogen replacement therapy in diabetic ovariectomized female rats subjected to transient forebrain ischemia.

  2002cites this paper
• Estrogen and neuroprotection: from clinical observations to molecular mechanisms

  2002cites this paper
• Oral Contraception and Postmenopausal Estrogen Replacement Therapy

  2002cites this paper
• Postmenopausal Hormone Replacement Therapy and the Primary Prevention of Cardiovascular Disease

  2002cites this paper
• Protective Effects of Estrogen on Aging and Damaged Neural Systems

  2002cites this paper
• Healthy Postmenopausal Women Receiving HRT Are Not at Risk for Early Coronary Events: Results from 2 Large Clinical Trials

  2002cites this paper
• CHAPTER 12 : MENOPAUSE AND DISORDERS OF NEUROLOGIC FUNCTION , MENTAL HEALTH , AND THE EYE

  2002cites this paper
• Menopause and ischaemic stroke: basic, clinical and epidemiological considerations. The role of hormone replacement.

  2002cites this paper
• Maximizing health in menopausal women with disabilities

  2002cites this paper
• Comparison of Tibolone and Conjugated Equine Estrogens Effects on Carotid Artery Atherosclerosis of Postmenopausal Monkeys

  2002cites this paper
• Postmenopausal Hormone Replacement Therapy Scientific Review

  2002cites this paper
• Conjugated estrogen administration improves common carotid artery elastic properties in normotensive postmenopausal women

  2002cites this paper
• Hormone Replacement Therapy and Mortality for Ischaemic Heart Disease, Cerebrovascular Diseases and Breast Cancer in Italy and the U.S.A.

  2002cites this paper
• Postmenopausal hormone therapy and the risk of cardiovascular disease: the epidemiologic evidence.

  2002cites this paper
• Menopause and Disorders of Neurological Function and Mental Health

  2002cites this paper
• Hormone replacement therapy and associated risk of stroke in postmenopausal women.

  2002influential citation
• Postmenopausal Hormone Therapy and Risk of Stroke: The Heart and Estrogen-progestin Replacement Study (HERS)

  2001cites this paper
• Pro: Postmenopausal hormone replacement therapy improves outcome in women undergoing coronary artery bypass graft surgery.

  2001cites this paper
• A clinical trial of estrogen-replacement therapy after ischemic stroke.

  2001cites this paper
• Neuroprotection by estradiol.

  2001cites this paper
• Evidence-based practice in women's health: hormone therapy for women at menopause.

  2001cites this paper
• Estrogens modulate experimentally induced apoptosis of granule cells in the adult hippocampus

  2001cites this paper
• Relaxant effects of 17-beta-estradiol in cerebral arteries through Ca(2+) entry inhibition.

  2001cites this paper
• Acute Cerebrovascular Disease in Women

  2001cites this paper
• Estrogens: trophic and protective factors in the adult brain.

  2001cites this paper
• Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association.

  2001cites this paper
• Hormone replacement therapy and ischemic stroke severity in women

  2001cites this paper
• Carotid Vascular Resistance in Long‐Term Estrogen Users

  2001cites this paper
• Postmenopausal hormone therapy and primary prevention of cardiovascular disease -- Nurses' health study 20-year follow-up.

  2001cites this paper
• Association of serum estrogen level and ischemic neuroprotection in female rats.

  2001cites this paper
• Hormone replacement therapy and stroke: risk, protection or no effect?

  2001cites this paper
• HORMONE REPLACEMENT THERAPY AND CORONARY HEART DISEASE

  2001cites this paper
• Critical Comment Postmenopausal hormone therapy and primary prevention of cardiovascular disease — Nurses' health study 20-year follow-up

  2001cites this paper
• Relaxant Effects of 17-β-Estradiol in Cerebral Arteries through Ca2+ Entry Inhibition

  2001cites this paper
• Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association.

  2001cites this paper
• Primary stroke prevention

  2001cites this paper
• Estrogen reduces mouse cerebral artery tone through endothelial NOS- and cyclooxygenase-dependent mechanisms.

  2000cites this paper
• Acidente vascular encefálico: conceituação e fatores de risco

  2000cites this paper
• A Prospective, Observational Study of Postmenopausal Hormone Therapy and Primary Prevention of Cardiovascular Disease

  2000cites this paper
• Hormone replacement therapy and coronary heart disease. A new debate.

  2000cites this paper
• Gender differences and the effects of synthetic exogenous and non-synthetic estrogens in focal cerebral ischemia.

  2000cites this paper
• International trends in mortality from stroke, 1968 to 1994.

  2000cites this paper
• Ischemic stroke: acute management and secondary prevention.

  2000cites this paper
• Estrogen as a Neuroprotectant in Stroke

  2000cites this paper
• Neuroprotective effects of female gonadal steroids in reproductively senescent female rats.

  2000cites this paper
• [Female hormones and migraine].

  2000cites this paper
• Migraine, Menopause and Hormonal Replacement Therapy

  2000cites this paper
• Risk of hormone replacement therapy in stroke patients

  2000cites this paper
• Stroke in Estrogen Receptor-α–Deficient Mice

  2000cites this paper
• Post-Menopausal Hormone Replacement Therapy and Stroke Risk

  2000cites this paper
• Estrogen Receptor Antagonist ICI182,780 Exacerbates Ischemic Injury in Female Mouse

  2000cites this paper